HomeTwist Bioscience (TWST) Market Cap
Track the latest market capitalisation and see how the company's value has changed over time.
Track the latest market capitalisation and see how the company's value has changed over time.
As of 07 September 2026, Twist Bioscience's market cap was $7.61B
This places Twist Bioscience among the largest companies by market capitalisation.
Market cap (market capitalisation) is the total value of a company's shares on the stock market – calculated by multiplying the number of outstanding shares by its current share price.
The table below shows Twist Bioscience's fiscal year-end market capitalisation, providing a reference point for its valuation aligned with its financial reporting periods. This helps illustrate how the company's market value has evolved across different years of operation.
|
Date |
Twist Bioscience market cap (USD) |
Change (%) |
|
September 2025 |
$1.70B |
-35.83% |
|
September 2024 |
$2.65B |
+127.62% |
|
September 2023 |
$1.16B |
-41.46% |
|
September 2022 |
$1.99B |
N/A |
The table below shows other leading companies in the same sector include Jazz Pharmaceuticals, Ginkgo Bioworks, Lantheus, and Prothena Corp.
| Name | Market Capitalization |
|---|---|
| Jazz Pharmaceuticals | $14.98B |
| Ginkgo Bioworks | $418.16M |
| Lantheus | $6.69B |
| Prothena Corp | $527.00M |
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.
Why choose Capital.com? Our numbers speak for themselves
Capital.com Group